Skip to content
BenevolentAI logo

BenevolentAI Alternatives & Competitors

12 companies similar to BenevolentAI — Technology in service of life.

Companies similar to BenevolentAI

BenchSci logo — alternative to BenevolentAI

BenchSci

We empower scientists with the world’s most advanced biomedical artificial intelligence.

Superbio.ai logo — alternative to BenevolentAI

Superbio.ai

World’s first AI store for biology

Candid Therapeutics logo — alternative to BenevolentAI

Candid Therapeutics

Developing innovative therapeutics that can materially improve the lives of patients

Atomwise logo — alternative to BenevolentAI

Atomwise

Better Medicines Faster

Rival Readout

Competing with BenevolentAI? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
Partex.AI Technology logo — alternative to BenevolentAI

Partex.AI Technology

The experts in AI technology for drug discovery and development.

Causaly logo — alternative to BenevolentAI

Causaly

Unlock R&D productivity with the most complete AI platform for life sciences.

ONTOFORCE logo — alternative to BenevolentAI

ONTOFORCE

Through our data and technology solutions, we transform data into actionable insights, and...

Vilya logo — alternative to BenevolentAI

Vilya

Compute Beyond Nature

AcademicLabs logo — alternative to BenevolentAI

AcademicLabs

AI-powered scientific intelligence platform for early-stage research and innovation scouti...

Nextnet logo — alternative to BenevolentAI

Nextnet

Where researchers love researching

Iambic logo — alternative to BenevolentAI

Iambic

Better technology for better medicines | Nasdaq: IAM

iktos logo — alternative to BenevolentAI

iktos

Artificial intelligence for new drug design

About BenevolentAI

BenevolentAI, founded in 2013 and headquartered in London, UK, operates at the intersection of AI, Big Data, Biotechnology, Pharmaceutical, and Machine Learning. The company's mission, encapsulated in its slogan, "Technology in service of life," is to enhance and protect human quality of life through advanced technolog...

Services

AI and Machine Learning Solutions, Life Science Data Analysis, R&D Decision Making Support

Target Customers

Scientists, Research & Development Teams, Life Sciences Executives

Business keywords

AI-enabled Drug Discovery, Clinical-stage Biotechnology, Strategic Decision Intelligence, Biomedical Knowledge Integration, AI Platform Development, Life Sciences Ecosystem, Collaborative Drug Programs, AI For Scientific Advancement, Machine Learning In Healthcare, Deep Learning In Biotechnology, Drug Development Innovation, Big Data In Life Sciences, AI-driven Research And Development, TechBio Solutions

Business Model

B2B, Platform, SaaS

Revenue Model

Subscription, Service Fee, Usage Based

Frequently Asked Questions

Companies similar to BenevolentAI include BenchSci, Superbio.ai, Candid Therapeutics, Atomwise, Partex.AI Technology. They work in Biotechnology and Pharmaceutical.
Bounce Watch lists 12 companies that share BenevolentAI's industries and are closest to it in business tags, services, target customers, business model and size.
BenevolentAI, founded in 2013 and headquartered in London, UK, operates at the intersection of AI, Big Data, Biotechnology, Pharmaceutical, and Machine Learning. The company's mission, encapsulated in its slogan, "Technology in service of life," is to enhance and protect human quality of life through advanced technolog...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around BenevolentAI: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at BenevolentAI on 24 Aug 2026. The 12 companies listed here were last checked between 5 Jul 2025 and 1 Oct 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout